Cited by 249Cardiovascular Syncope and Autonomic DisordersHeart Rate Variability and Autonomic ControlVestibular and auditory disorders

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Midodrine: a role in the management of neurocardiogenic syncope

Open access

Ward, C R, Gray, J C, Gilroy, J J, Kenny, R A·1998·Heart

DOI 10.1136/hrt.79.1.45PMC PMC1728578

Open this paper in CoChat — free account Open PDF

Abstract

Objective: To determine the benefit of midodrine, an α agonist, on symptom frequency and haemodynamic responses during head up tilt in patients with neurocardiogenic syncope. Setting: Cardiovascular investigation unit (a secondary and tertiary referral centre for the investigation and management of syncope). Patients: 16 outpatients (mean (SD) age 56 (18) years; five men) with frequent hypotensive symptoms (more than two syncopal episodes and fewer than 20 symptom free days per month), and reproducible syncope with glyceryl trinitrate (GTN) during head up tilt. Design and intervention: Randomised double blind placebo controlled study. Patients were randomised to receive either placebo or midodrine for one month. Symptom events were recorded during each study month. At the end of each study month patients completed a quality of life scoring scale (Short Form 36) and a global assessment of therapeutic response. They received GTN with head up tilt for measurement of heart rate (electrocardiography), phasic blood pressure (digital photoplethysmography), and thoracic fluid index (transthoracic impedance plethysmography) during symptom provocation. Results: Patients administered midodrine had an average of 7.3 more symptom free days than those who received placebo (95% confidence interval (CI) 4.6 to 9; p < 0.0001). Eleven patients reported a positive therapeutic response with midodrine (p = 0.002). All domains of quality of life showed improvement with midodrine, in particular physical function (8.1; 95% CI 3.7 to 12.2), energy and vitality (14.6; 95% CI 7.3 to 22.1), and change in health status (22.2; 95% CI 11 to 33.4 ). Fourteen patients who were given placebo had tilt induced syncope compared with six given midodrine (p = 0.01). Baseline supine systolic blood pressure was higher and heart rate lower in patients who received midodrine than in those who were given placebo ( p < 0.05). A lower thoracic fluid index in patients administered midodrine indicates increased venous return when supine and during head up tilt. There were no serious adverse effects. Conclusions: Midodrine had a conspicuous beneficial effect on symptom frequency, symptoms during head up tilt, and quality of life. Midodrine is recommended for the treatment of neurocardiogenic syncope in patients with frequent symptoms.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/hrt.79.1.45

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and Clinical Tests of Validity in Measuring Physical and Mental Health Constructs
MCHORNEY, C. A., JOHNE, W., & ANASTASIAE, R. (1993) · Medical Care · doi:10.1097/00005650-199303000-00006 · Cited by 6,681
Development and evaluation of an impedance cardiac output system.
Kubicek, W. G., Karnegis, J. N., PATTERSON, R. P., Witsoe, D. A., & Mattson, R. H. (1966) · PubMed · Cited by 1,143
HEAD-UP TILT: A USEFUL TEST FOR INVESTIGATING UNEXPLAINED SYNCOPE
Kenny, R. A., Bayliss, J. M., Ingram, A., & Sutton, R. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91665-x · Cited by 777
Self-citation
Provocation of Bradycardia and Hypotension by Isoproterenol and Upright Posture in Patients with Unexplained Syncope
Almquist, A. K., Goldenberg, I. F., Milstein, S., Chen, M. Y., Chen, X., Hansen, R., Gornick, C. C., & Benditt, D. G. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902093200603 · Cited by 644
Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine
Jankovic, J., Gilden, J. L., Hiner, B. C., Kaufmann, H., Brown, D. C., Coghlan, C. H., Rubin, M., & Fouad-Tarazi, F. M. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90230-m · Cited by 396
IMPEDANCE CARDIOGRAPHY AS A NONINVASIVE METHOD OF MONITORING CARDIAC FUNCTION AND OTHER PARAMETERS OF THE CARDIOVASCULAR SYSTEM*
Kubicek, W. G., PATTERSON, R. P., & Witsoe, D. A. (1970) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1970.tb17735.x · Cited by 396
Non-invasive continuous finger blood pressure measurement during orthostatic stress compared to intra-arterial pressure
Imholz, B. P. M., Settels, J. J., van der Meiracker, A. H., Wesseling, K. H., & Wieling, W. (1990) · Cardiovascular Research · doi:10.1093/cvr/24.3.214 · Cited by 344
The vasovagal response
van Lieshout, J. J., Wieling, W., Karemaker, J. M., & Eckberg, D. L. (1991) · Clinical Science · doi:10.1042/cs0810575 · Cited by 323
The Usefulness of Head‐Up Tilt Testing and Hemodynamic Investigations in the Workup of Syncope of Unknown Origin
ABI‐SAMRA, F. M., Maloney, J. D., Fouad-Tarazi, F. M., & CASTLE, L. W. (1988) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1988.tb03973.x · Cited by 306
Impairment of physical and psychosocial function in recurrent syncope
Linzer, M., Pontinen, M., Gold, D. T., Divine, G. W., Felder, A., & Blair Brooks, W. (1991) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(91)90005-t · Cited by 296

Show all 34 references

Research works printed but not linked: 3

McIntosh, 1996, Use of sublingual glyceryl trinitrate during head-up tilt: a provocative test for reproduction of neurocardiogenic symptoms in unexplained syncope., Cardiology in the Elderly, 4, 33
Fitzpatrick, 1991, A randomised trial of medical therapy in “malignant vasovagal syndrome” or “neurally-mediated bradycardia/hypotension syndrome”., European Journal of Cardiac Pacing and Electrophysiology, 2, 99
Erhringer, 1971, Studies on the peripheral haemodynamics in man after intravenous infusion of a small dose of di-1-(2′,5′-dimethoxyphenyl)-2-glycinamido-ethanol-(1)-hydrochloride., Int J Clin Pharmacol Ther Toxicol, 4, 415

Sorted by citations

Guidelines for the diagnosis and management of syncope (version 2009): The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC)
Developed in collaboration with, European Heart Rhythm Association (EHRA), Heart Failure Association (HFA), and Heart Rhythm Society (HRS), societies, E. B. T. F., European Society of Emergency Medicine (EuSEM), European Federation of Internal Medicine (EFIM), European Union Geriatric Medicine Society (EUGMS), American Geriatrics Society (AGS), European Neurological Society (ENS), et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp298 · Cited by 2,040
Self-citation
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols
Carruthers, B. M., Jain, A. K., De Meirleir, K. L., Peterson, D. L., Klimas, N. G., Lerner, A. M., Bested, A. C., Flor-Henry, P., Joshi, P., Powles, A. C. P., et al. (2003) · Journal of Chronic Fatigue Syndrome · doi:10.1300/j092v11n01_02 · Cited by 1,180
2015 Heart Rhythm Society Expert Consensus Statement on the Diagnosis and Treatment of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Vasovagal Syncope
Sheldon, R. S., Grubb, B. P., Olshansky, B., Shen, W.-K., Calkins, H., Brignole, M., Raj, S. R., Krahn, A. D., Morillo, C. A., Stewart, J. M., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.03.029 · Cited by 1,013
Guidelines on management (diagnosis and treatment) of syncope
Brignole, M. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2739 · Cited by 951
Guidelines on Management (diagnosis and treatment) of syncope ? update 2004
Brignole, M., Alboni, P., Benditt, D. G., Bergfeldt, L., Blanc, J., Thomsen, P. E. B., van Dijk, J. G., Fitzpatrick, A. P., Hohnloser, S. H., Janousek, J., et al. (2004) · EP Europace · doi:10.1016/j.eupc.2004.08.008 · Cited by 650
Self-citation
2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope
Shen, W.-K., Sheldon, R. S., Benditt, D. G., Cohen, M. I., Forman, D. E., Goldberger, Z. D., Grubb, B. P., Hamdan, M. H., Krahn, A. D., Link, M. S., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.03.004 · Cited by 478
New classification of haemodynamics of vasovagal syncope: beyond the VASIS classification Analysis of the pre-syncopal phase of the tilt test without and with nitroglycerin challenge
Brignole, M. (2000) · Europace · doi:10.1053/eupc.1999.0064 · Cited by 451
2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Shen, W.-K., Sheldon, R. S., Benditt, D. G., Cohen, M. I., Forman, D. E., Goldberger, Z. D., Grubb, B. P., Hamdan, M. H., Krahn, A. D., Link, M. S., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000499 · Cited by 463
Multifactorial intervention after a fall in older people with cognitive impairment and dementia presenting to the accident and emergency department: randomised controlled trial
Shaw, F. E., Bond, J., Richardson, D. A., Dawson, P., Steen, I. N., McKeith, I. G., & Kenny, R. A. (2003) · BMJ · doi:10.1136/bmj.326.7380.73 · Cited by 414
Self-citation
2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Shen, W.-K., Sheldon, R. S., Benditt, D. G., Cohen, M. I., Forman, D. E., Goldberger, Z. D., Grubb, B. P., Hamdan, M. H., Krahn, A. D., Link, M. S., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000498 · Cited by 411
2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope
Shen, W.-K., Sheldon, R. S., Benditt, D. G., Cohen, M. I., Forman, D. E., Goldberger, Z. D., Grubb, B. P., Hamdan, M. H., Krahn, A. D., Link, M. S., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.003 · Cited by 327
Permanent Cardiac Pacing Versus Medical Treatment for the Prevention of Recurrent Vasovagal Syncope: A Multicenter, Randomized, Controlled Trial
Ammirati, F., Colivicchi, F., & Santini, M. (2001) · Circulation · doi:10.1161/hc2601.091708 · Cited by 299
Prevention of Syncope Trial (POST): A Randomized, Placebo-Controlled Study of Metoprolol in the Prevention of Vasovagal Syncope
Sheldon, R., Connolly, S., Rose, S., Klingenheben, T., Krahn, A., Morillo, C., Talajic, M., Ku, T., Fouad-Tarazi, F., Ritchie, D., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.535161 · Cited by 278
Guía de práctica clínica para el diagnóstico y manejo del síncope (versión 2009)
Moya‐Mitjans, À., Sutton, R., Ammirati, F., Blanc, J., Brignole, M., Dahm, J. B., Deharo, J., Gajek, J. J., Gjesdal, K., Krahn, A. D., et al. (2009) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(09)73541-8 · Cited by 277
Patients with recurrent falls attending Accident & Emergency benefit from multifactorial intervention—a randomised controlled trial
Davison, J., Bond, J., Dawson, P., Steen, I. N., & Kenny, R. A. (2005) · Age and Ageing · doi:10.1093/ageing/afi053 · Cited by 251
Self-citation
Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos syndrome
Rowe, P. C., Barron, D. F., Calkins, H., Maumenee, I. H., Tong, P. Y., & Geraghty, M. T. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70173-3 · Cited by 230
Water drinking acutely improves orthostatic tolerance in healthy subjects
Schroeder, C., Bush, V. E., Norcliffe, L. J., Luft, F. C., Tank, J., Jordan, J., & Hainsworth, R. (2002) · Circulation · doi:10.1161/01.cir.0000038921.64575.d0 · Cited by 227
Neurocardiogenic Syncope
Grubb, B. P. (2005) · New England Journal of Medicine · doi:10.1056/nejmcp042601 · Cited by 208
Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study
Madrid, A. H., Ortega, J., Rebollo, J. G., Manzano, J. G., Segovia, J. G., Sánchez, A., Peña, G., & Moro, C. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01155-4 · Cited by 205
Effect of Etilefrine in Preventing Syncopal Recurrence in Patients With Vasovagal Syncope: A Double-Blind, Randomized, Placebo-Controlled Trial
Raviele, A., Brignole, M., Sutton, R., Alboni, P., Giani, P., Menozzi, C., & Moya, A. (1999) · Circulation · doi:10.1161/01.cir.99.11.1452 · Cited by 201
Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study
PEREZ‐LUGONES, A., SCHWEIKERT, R., PAVIA, S., SRA, J., AKHTAR, M., JAEGER, F., TOMASSONI, G. F., SALIBA, W., LEONELLI, F. M., BASH, D., et al. (2001) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2001.00935.x · Cited by 164
Vasovagal syncope
Fenton, A. M., Hammill, S. C., Rea, R. F., Low, P. A., & Shen, W.-K. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-9-200011070-00014 · Cited by 158
2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: Executive Summary
Shen, W.-K., Sheldon, R. S., Benditt, D. G., Cohen, M. I., Forman, D. E., Goldberger, Z. D., Grubb, B. P., Hamdan, M. H., Krahn, A. D., Link, M. S., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.002 · Cited by 155
Seizure versus syncope
McKeon, A. B., Vaughan, C. J., & Delanty, N. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70350-7 · Cited by 153
Neurocardiogenic syncope
Chen-Scarabelli, C. A., & Scarabelli, T. M. (2004) · BMJ · doi:10.1136/bmj.329.7461.336 · Cited by 147
Fludrocortisone Acetate to Treat Neurally Mediated Hypotension in Chronic Fatigue Syndrome: A Randomized Controlled Trial
Rowe, P. C., Calkins, H., DeBusk, K., McKenzie, R., Anand, R., Sharma, G., Cuccherini, B. A., Soto, N., Hohman, P., Snader, S., et al. (2001) · JAMA · doi:10.1001/jama.285.1.52 · Cited by 142
Midodrine in neurally mediated syncope: A double‐blind, randomized, crossover study
Kaufmann, H., Saadia, D., & Voustianiouk, A. (2002) · Annals of Neurology · doi:10.1002/ana.10293 · Cited by 137
Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients’ well-being
Flevari, P., LIVANIS, E. G., THEODORAKIS, G. N., Zarvalis, E., Mesiskli, T., & Kremastinos, D. T. H. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01974-5 · Cited by 137
Current Evaluation and Management of Syncope
Kapoor, W. N. (2002) · Circulation · doi:10.1161/01.cir.0000031168.96232.ba · Cited by 135
Midodrine for orthostatic hypotension and recurrent reflex syncope: A systematic review
Izcovich, A., González Malla, C., Manzotti, M., Catalano, H. N., & Guyatt, G. (2014) · Neurology · doi:10.1212/wnl.0000000000000815 · Cited by 131
The Postural Orthostatic Tachycardia Syndrome: A Potentially Treatable Cause of Chronic Fatigue, Exercise Intolerance, and Cognitive Impairment in Adolescents
Karas, B. J., Grubb, B. P., BOEHM, K., & Kip, K. T. (2000) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2000.tb06760.x · Cited by 129
The efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope
Qingyou, Z., Junbao, D., & Chaoshu, T. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.07.031 · Cited by 108
Nonpharmacological treatment of reflex syncope
Wieling, W., Colman, N., Krediet, C. T. P., & Freeman, R. (2004) · Clinical Autonomic Research · doi:10.1007/s10286-004-1009-x · Cited by 102
The management of vasovagal syncope
Kenny, R. A., & McNicholas, T. (2016) · QJM · doi:10.1093/qjmed/hcw089 · Cited by 100
Self-citation
Vasovagal Syncope in the Older Patient
Tan, M. P., & Parry, S. W. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.11.025 · Cited by 92
Effectiveness of midodrine treatment in patients with recurrent vasovagal syncope not responding to non-pharmacological treatment (STAND-trial)
Romme, J. J. C. M., van Dijk, N., Go-Schon, I. K., Reitsma, J. B., & Wieling, W. (2011) · Europace · doi:10.1093/europace/eur200 · Cited by 83
Medical Therapy and Physical Maneuvers in the Treatment of the Vasovagal Syncope and Orthostatic Hypotension
Raj, S. R., & Coffin, S. T. (2013) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2012.11.004 · Cited by 81
Syncope in childhood
McLeod, K. A. (2003) · Archives of Disease in Childhood · doi:10.1136/adc.88.4.350 · Cited by 79
The Second Prevention of Syncope Trial (POST II)—a randomized clinical trial of fludrocortisone for the prevention of neurally mediated syncope: Rationale and study design
Raj, S. R., Rose, S., Ritchie, D., & Sheldon, R. S. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.03.013 · Cited by 78
Age-Dependent Effect of β-Blockers in Preventing Vasovagal Syncope
Sheldon, R. S., Morillo, C. A., Klingenheben, T., Krahn, A. D., Sheldon, A., & Rose, M. S. (2012) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.112.974386 · Cited by 72
Perturbed and spontaneous regional cerebral blood flow responses to changes in blood pressure after high-level spinal cord injury: the effect of midodrine
Phillips, A. A., Krassioukov, A. V., Ainslie, P. N., & Warburton, D. E. R. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01090.2013 · Cited by 72
Midodrine for the Prevention of Vasovagal Syncope
Sheldon, R. S., Faris, P., TANG, A. S. L., Paredes, F. A., Guzmán, J. C., Márquez, M. F., Morillo, C. A., Krahn, A. D., Kuś, T., Ritchie, D., et al. (2021) · Annals of Internal Medicine · doi:10.7326/m20-5415 · Cited by 70
Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension: a phase 4, double-blind, placebo-controlled, randomized, tilt-table study
Smith, W. B., Wan, H., Much, D. R., Robinson, A., & Martin, P. T. (2016) · Clinical Autonomic Research · doi:10.1007/s10286-016-0363-9 · Cited by 67
Drugs and pacemakers for vasovagal, carotid sinus and situational syncope
Romme, J. J., Reitsma, J. B., Black, C. N., Colman, N., Scholten, R. J., Wieling, W., & Van Dijk, N. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004194.pub3 · Cited by 65
Efficacy and safety of midodrine hydrochloride in patients with refractory vasovagal syncope
Samniah, N., Sakaguchi, S., Lurie, K. G., Iskos, D., & Benditt, D. G. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01594-6 · Cited by 61
Management and therapy of vasovagal syncope: A review
Aydin, M. A. (2010) · World Journal of Cardiology · doi:10.4330/wjc.v2.i10.308 · Cited by 63
Carotid sinus syndrome: Progress in understanding and management
Sutton, R. (2014) · Global Cardiology Science and Practice · doi:10.5339/gcsp.2014.18 · Cited by 58
Syncope
Benditt, D. G., & Nguyen, J. T. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.065 · Cited by 55
Sympathetic dysfunction in vasovagal syncope and the postural orthostatic tachycardia syndrome
Lambert, É., & Lambert, G. W. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00280 · Cited by 56
Diagnosis and management of patients with blackouts
Fitzpatrick, A. P., & Cooper, P. N. (2006) · Heart · doi:10.1136/hrt.2005.068650 · Cited by 55
Pharmacologic approaches to therapy for vasovagal syncope
Calkins, H. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00626-8 · Cited by 52
A randomized crossover study to evaluate Ro 115–1240, a selective α 1A/1L ‐adrenoceptor partial agonist in women with stress urinary incontinence
Musselman, D. M., Ford, A. P. D. W., Gennevois, D., Harbison, M. L., Laurent, A. L., Mokatrin, A., Stoltz, R. R., & Blue, D. R. (2003) · British Journal of Urology · doi:10.1111/j.1464-410x.2004.04560.x · Cited by 51
Diagnostic Evaluation and Management of Patients with Syncope
Schnipper, J. L., & Kapoor, W. N. (2001) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70321-7 · Cited by 49
Midodrine prevents orthostatic intolerance associated with simulated spaceflight
Ramsdell, C. D., Mullen, T. J., Sundby, G. H., Rostoft, S., Sheynberg, N., Aljuri, N., Maa, M. T., Mukkamala, R., Sherman, D., Toska, K., et al. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.90.6.2245 · Cited by 49
Randomized Clinical Trials of Neurally Mediated Syncope
Brignole, M. (2003) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.14.s9.7.x · Cited by 48
Long-term follow-up of children and adolescents with syncope; predictor of syncope recurrence
Kouakam, C. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2577 · Cited by 47
Panel consensus
Bloomfield, D. M., Sheldon, R. S., Grubb, B. P., Calkins, H. G., & Sutton, R. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00694-3 · Cited by 47
Pharmacokinetic and pharmacodynamic effects of midodrine on blood pressure, the autonomic nervous system, and plasma natriuretic peptides: a prospective, randomized, single-blind, two-period, crossover, placebo-controlled study
Lamarre-Cliché, M., du Souich, P., de Champlain, J., & Larochelle, P. M. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.09.001 · Cited by 45
Kommentar zu den Leitlinien zur Diagnostik und Therapie von Synkopen—der Europäischen Gesellschaft für Kardiologie 2001 und dem Update 2004
Seidl, K., Schuchert, A., Tebbenjohanns, J., & Hartung, W. (2005) · Zeitschrift für Kardiologie · doi:10.1007/s00392-005-0230-5 · Cited by 43
Permanent cardiac pacing vs. medical treatment for the prevention of recurrent vasovagal syncope
Ammirati, F., Colivicchi, F., & Santini, M. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00501-3 · Cited by 45
Are treatments for vasovagal syncope effective? A meta-analysis
Vyas, A., Swaminathan, P. D., Zimmerman, M. B., & Olshansky, B. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.04.144 · Cited by 44
The management of vasovagal syncope
Parry, S. W. (1999) · QJM · doi:10.1093/qjmed/92.12.697 · Cited by 42
Rationale for the prevention of syncope trial IV: assessment of midodrine
Raj, S. R., Faris, P., McRae, M., & Sheldon, R. S. (2012) · Clinical Autonomic Research · doi:10.1007/s10286-012-0167-5 · Cited by 39
Postural Orthostatic Tachycardia Syndrome (POTS): An Update for Clinical Practice
Sebastian, S. A., Co, E. L., Panthangi, V., Jain, E., Ishak, A., Shah, Y., Vasavada, A. M., & Padda, I. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101384 · Cited by 41
Reflex syncope: Diagnosis and treatment
Sutton, R. (2017) · Journal of Arrhythmia · doi:10.1016/j.joa.2017.03.007 · Cited by 34
Midodrine for the prevention of vasovagal syncope: a systematic review and meta-analysis
Lei, L. Y., Raj, S. R., & Sheldon, R. S. (2021) · EP Europace · doi:10.1093/europace/euab323 · Cited by 36
2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: Executive summary
Shen, W.-K., Sheldon, R. S., Benditt, D. G., Cohen, M. I., Forman, D. E., Goldberger, Z. D., Grubb, B. P., Hamdan, M. H., Krahn, A. D., Link, M. S., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.03.005 · Cited by 34
Key challenges in the current management of syncope
Sutton, R., Brignole, M., & Benditt, D. G. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.102 · Cited by 33
Midodrine
Liou, D. Z., Warren, H., Maher, D. P., Soukiasian, H. J., Melo, N., Salim, A., & Ley, E. J. (2013) · CHEST Journal · doi:10.1378/chest.12-3081 · Cited by 33
Tilt Training: Does It Have a Role in Preventing Vasovagal Syncope?
Gurevitz, O. T., Barsheshet, A., Bar-Lev, D. S., Zimlichman, E., Rosenfeld, G., Benderly, M., Luria, D. M., Amital, H., Kreiss, Y., Eldar, M., et al. (2007) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2007.00898.x · Cited by 33
Symptom provocation studies in psychiatric disorders: scientific value, risks, and future
D’Souza, D. C., Berman, R., Krystal, J. H., & Charney, D. S. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00209-7 · Cited by 32
Pathophysiology and management of neurocardiogenic syncope.
Nair, N., Padder, F. A., & Kantharia, B. K. (2003) · PubMed · Cited by 28
Pharmacological norepinephrine transporter inhibition for the prevention of vasovagal syncope in young and adult subjects: A systematic review and meta-analysis
Lei, L. Y., Raj, S. R., & Sheldon, R. S. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.02.033 · Cited by 28
Role of pacing in the treatment of vasovagal syncope11This article may contain discussion of off-label or investigational uses (not yet approved by the FDA) of various therapeutic agents. Please refer to the box provided on page 2Q of this supplement for a disclosure of such agents.
Sheldon, R. S. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00627-x · Cited by 28
Components of clinical trials for vasovagal syncope
Sheldon, R. S. (2001) · EP Europace · doi:10.1053/eupc.2001.0168 · Cited by 28
Management of vasovagal syncope: 2004
Sheldon, R. S., Morillo, C. A., & Krahn, A. D. (2004) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2.6.915 · Cited by 26
Midodrine Hydrochloride in the Treatment of Vasovagal Syncope
Mitro, P., Trejbal, D., & Rybár, R. (1999) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1999.tb00381.x · Cited by 26
Syncope in adults: Systematic review and proposal of a diagnostic and therapeutic algorithm
Rosanio, S., Schwarz, E. R., Ware, D. L., & Vitarelli, A. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.11.021 · Cited by 25
Interventions aimed to increase average 24-h systolic blood pressure reduce blood pressure drops in patients with reflex syncope and orthostatic intolerance
Groppelli, A., Rivasi, G., Fedorowski, A., de Lange, F. J., Russo, V., Maggi, R., Capacci, M., Nawaz, S., Comune, A., Bianchi, L., et al. (2024) · EP Europace · doi:10.1093/europace/euae026 · Cited by 23
Role of yoga as an adjunctive therapy in patients with neurocardiogenic syncope: a pilot study
Gunda, S., Kanmanthareddy, A., Atkins, D., Bommana, S., Pimentel, R., Drisko, J., Biase, L. D., Beheiry, S., Hao, S. C., Natale, A., et al. (2015) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-015-9996-1 · Cited by 22
Syncope and orthostatic intolerance
Weimer, L. H., & Williams, O. A. (2003) · Medical Clinics of North America · doi:10.1016/s0025-7125(03)00007-5 · Cited by 22
Non-invasive management of vasovagal syncope
Coffin, S. T., & Raj, S. R. (2014) · Autonomic Neuroscience · doi:10.1016/j.autneu.2014.06.004 · Cited by 22
Chronic Activation of Endothelin B Receptors
Fink, G. D., Li, M., Lau, Y. E., Osborn, J. W., & Watts, S. W. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.094821 · Cited by 21
Drug Treatment of Orthostatic Hypotension Because of Autonomic Failure or Neurocardiogenic Syncope
Lamarre-Cliché, M. (2002) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200202010-00004 · Cited by 21
α‐Adrenoceptor agonists for the treatment of vasovagal syncope: a meta‐analysis of worldwide published data
Liao, Y., Li, X., Zhang, Y., Chen, S., Tang, C., & Du, J. (2009) · Acta Paediatrica · doi:10.1111/j.1651-2227.2009.01289.x · Cited by 21
Dizziness and syncope in adolescence
McLEOD, K. A. (2001) · Heart · doi:10.1136/heart.86.3.350 · Cited by 21
Orthostatic challenge reveals impaired vascular resistance control, but normal venous pooling and capillary filtration in familial dysautonomia
Brown, C., Stemper, B., Welsch, G. H., Bryś, M., Axelrod, F. B., & Hilz, M. J. (2003) · Clinical Science · doi:10.1042/cs1040163 · Cited by 21
Management of vasovagal syncope
Ballantyne, B. A., Letourneau-Shesaf, S., & Raj, S. R. (2021) · Autonomic Neuroscience · doi:10.1016/j.autneu.2021.102904 · Cited by 21
WORK-RELATED STRESS AND COPING: A SURVEY ON MEDICAL AND SURGICAL NURSES IN A MALAYSIAN TEACHING HOSPITAL
Emilia, Z., Ismail, N. H., Ehsan, S. D., Latif, Y., & Razak, B. T. (2007) · Cited by 20
Severe Hypertension and Bradycardia Secondary to Midodrine Overdose
Wong, L. Y., Wong, A., Robertson, T. A., Burns, K., Roberts, M. S., & Isbister, G. K. (2016) · Journal of Medical Toxicology · doi:10.1007/s13181-016-0574-4 · Cited by 19
Familial Vasovagal Syncope Associated With Migraine
Daas, A., Mimouni-Bloch, A., Rosenthal, S., & Shuper, A. (2008) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2008.09.003 · Cited by 19
Prospective Evaluation of a Two‐Step Therapeutic Strategy in Neurocardiogenic Syncope: Midodrine as Second Line Treatment in Patients Refractory to β‐Blockers
Klingenheben, T., Credner, S., & HOHNLOSER, S. H. (1999) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1999.tb00439.x · Cited by 19
The Vasovagal Syncope and Pacing (Synpace) trial: rationale and study design
Raviele, A. (2001) · EP Europace · doi:10.1053/eupc.2001.0192 · Cited by 19
Neurocardiogenic Syncope
Gatzoulis, K. A., & TOUTOUZAS, P. K. (2001) · Drugs · doi:10.2165/00003495-200161100-00005 · Cited by 18
Pharmacological treatment of reflex syncope
Kaufmann, H., & Freeman, R. L. (2004) · Clinical Autonomic Research · doi:10.1007/s10286-004-1010-4 · Cited by 18
Management of Vasovagal Syncope
Atiga, W. L., Rowe, P. C., & Calkins, H. G. (1999) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1999.tb00270.x · Cited by 18
Is There an Effective Treatment for Neurally Mediated Syncope?
Kapoor, W. N. (2003) · JAMA · doi:10.1001/jama.289.17.2272 · Cited by 18
Treatment of Neurally Mediated Reflex Syncope
Guzmán, J. C., Armaganijan, L., & Morillo, C. A. (2012) · Cardiology Clinics · doi:10.1016/j.ccl.2012.10.007 · Cited by 17
Diagnosis and Treatment of Neurally Mediated Syncope
Kaufmann, H., & Bhattacharya, K. (2002) · The Neurologist · doi:10.1097/00127893-200205000-00004 · Cited by 17
Management of Neurogenic Orthostatic Hypotension
Arbique, D., Cheek, D. J., Welliver, M. D., & Vongpatanasin, W. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.10.014 · Cited by 17

Authors: Ward, C. R., Gray, J. C., Gilroy, J. J., & Kenny, R. A.
Affiliations: Royal Victoria Infirmary (GB)
Corresponding author: Kenny, R A
ORCID: Kenny, R A
Venue: Heart
Publisher: BMJ
Published: 1998-01-01
Volume: 79
Issue: 1
Pages: 45-49
ISSN: 1355-6037 (ISSN-L)
1468-201X
DOI: 10.1136/hrt.79.1.45
PMC: PMC1728578
OpenAlex: W2120769605
Semantic Scholar: 8c8b308da301fd99036cd9943d91f93c05304560
Cited by: 249
References: 34
Citations by year: 2025: 4 · 2024: 2 · 2023: 1 · 2022: 4 · 2021: 10 · 2020: 1 · 2019: 4 · 2018: 4 · 2017: 9 · 2016: 7 · 2015: 5 · 2014: 15 · 2013: 7 · 2012: 9
FWCI: 16.68
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Heart (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Syncope and Autonomic Disorders
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
Life Sciences › Neuroscience › Neurology › Vestibular and auditory disorders
Keywords: midodrine, vasovagal syncope, orthostatic intolerance, alpha-adrenergic agonists, head-up tilt, nitroglycerin, symptom frequency, quality of life, venous return, blood pressure, heart rate, adverse effects, treatment response assessment
MeSH terms: Adrenergic alpha-Agonists, Blood Pressure, Cardiography, Impedance, Double-Blind Method, Female, Heart Rate, Humans, Male, Middle Aged, Midodrine, Cross-Over Studies, Tilt-Table Test, Syncope, Vasovagal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Midodrine: a role in the management of neurocardiogenic syncope

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks